RxDoctor Payments Data

Joshua Ellwitz, MD

Orthopaedic Surgery of the Spine · Kalamazoo, MINPI 1063615854

Payments from drug & device makers

What this record shows

The money is spread across several categories — speaking fees (39.0%), royalties or licence payments and consulting fees — rather than concentrated in one kind of arrangement. Globus Medical accounts for 76.2% of it on its own, with 14 other manufacturers making up the rest. Reporting peaked in 2019 at $45,123 and has fallen 57.6% since, to $19,111 in 2025.

$150,368in general payments, 2019–2025

Across 427 payments — averaging $352.15 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Globus Medical$115K
  • Medtronic$15K
  • Bioventus LLC$11K
  • Stryker$5K
  • Si-bone, Inc.$2K
  • Abbott$1K
  • plus $1K from 9 others

What the payments were for

  • Royalty or licence$34,55623%
  • Consulting fees$25,90017%
  • Speaking & faculty fees$58,71339%
  • Travel & lodging$18,78912%
  • Food & beverage$12,2768%
  • Education$1340%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$150,368 in reported general payments places this provider in the 85th percentile of 37 orthopaedic surgery of the spine providers in Michigan.

See all orthopaedic surgery of the spine providers in Michigan

Medicare billing

Part B allowed, 2024
$255,878
Medicare patients
238
Services billed
680

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Naloxone Hcl22$1,409
Gabapentin47$619
Methocarbamol53$526
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen42$431
Oxycodone Hcl17$124
Meloxicam23$58

Paid to pharmacies, not to this prescriber.

Other orthopaedic surgery of the spine in Kalamazoo

See the full list for Michigan

Where these figures come from

Is this you, or does something look wrong? →